EFAVIRENZ for Hepatitis c: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 45 adverse event reports in the FDA FAERS database where EFAVIRENZ was used for Hepatitis c.
Most Reported Side Effects for EFAVIRENZ
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Virologic failure | 916 | 11.6% | 20 | 30 |
| Foetal exposure during pregnancy | 701 | 8.9% | 137 | 83 |
| Drug resistance | 654 | 8.3% | 15 | 40 |
| Drug interaction | 645 | 8.2% | 146 | 133 |
| Viral mutation identified | 641 | 8.1% | 5 | 10 |
| Depression | 602 | 7.6% | 141 | 149 |
| Pathogen resistance | 567 | 7.2% | 0 | 31 |
| Maternal exposure during pregnancy | 478 | 6.1% | 31 | 70 |
| Treatment failure | 390 | 4.9% | 38 | 17 |
| Immune reconstitution inflammatory syndrome | 301 | 3.8% | 47 | 148 |
| Death | 295 | 3.7% | 295 | 41 |
| Exposure during pregnancy | 251 | 3.2% | 26 | 39 |
| Treatment noncompliance | 222 | 2.8% | 13 | 47 |
| Abortion spontaneous | 221 | 2.8% | 39 | 44 |
| Lipodystrophy acquired | 203 | 2.6% | 1 | 19 |
Other Indications for EFAVIRENZ
Hiv infection (5,261)
Product used for unknown indication (1,314)
Antiretroviral therapy (580)
Acquired immunodeficiency syndrome (191)
Hiv test positive (64)
Perinatal hiv infection (41)
Prophylaxis against hiv infection (40)
Hiv infection who clinical stage iii (35)
Maternal exposure timing unspecified (33)
Hiv infection cdc category c (31)
Other Drugs Used for Hepatitis c
RIBAVIRIN (20,657)
PEGINTERFERON ALFA-2A (10,970)
LEDIPASVIR\SOFOSBUVIR (8,924)
DASABUVIR\OMBITASVIR\PARITAPREVIR\RITONAVIR (8,264)
SOFOSBUVIR (7,691)
SOFOSBUVIR\VELPATASVIR (4,956)
GLECAPREVIR\PIBRENTASVIR (4,016)
OMBITASVIR\PARITAPREVIR\RITONAVIR (2,906)
TELAPREVIR (2,604)
DASABUVIR (2,603)